ESG risk score 21.14
Environmental score 4.28
Social score 12.83
Governance score 4.02
ESG risk category Medium
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
Laboratorios Farmaceuticos Rovi, SA
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol ROVI:xmce
Currency EUR
BME Spanish Exchanges
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) 30.16%
1 year 63.66%
3 years 114.79%
Data provided by 
Key stats
Price/earnings (LTM) 30.1
Dividend yield (LTM) 0.92%
EPS (LTM) 2.75
Volatility (30 days) -
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About Laboratorios Farmaceuticos Rovi, SA
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments.
Sector Healthcare
Industry -
Market cap 4bn
Data provided by /
/ Frequently asked questions
To buy Laboratorios Farmaceuticos Rovi, SA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Laboratorios Farmaceuticos Rovi, SA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Laboratorios Farmaceuticos Rovi, SA is ROVI:xmce. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Laboratorios Farmaceuticos Rovi, SA has its primary listing on BME Spanish Exchanges. You can trade Laboratorios Farmaceuticos Rovi, SA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Laboratorios Farmaceuticos Rovi, SA is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Laboratorios Farmaceuticos Rovi, SA as part of a broader investment portfolio.